Institutional investors purchased a net $836.9 thousand shares of HROW during the quarter ended March 2019, and now own 60.15% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OPALEYE MANAGEMENT, INC. Bought 11.1 Thousand shares of Harrow Health Inc
MIRAE ASSET GLOBAL INVESTMENTS C... Sold 18.00 shares of Harrow Health Inc